CTU A Phase 2, Open-Label, Multicentre Study of FPI-2265 (225Ac-PSMA-I&T) and Olaparib in Participants with Metastatic Castration Resistant Prostate Cancer (mCRPC)

Gurney, Howard (Primary Chief Investigator)
Chapman, Nicola (Clinical Trial Unit Staff)
Quinlan, Gabriel (Clinical Trial Unit Staff)
TAIDI, Gina (Clinical Trial Unit Staff)
Martin, Lewis (Clinical Trial Unit Staff)
Armstrong, Emilia (Clinical Trial Unit Staff)
McHugh, Tracey (Clinical Trial Unit Staff)
Garcia, Michelle (Clinical Trial Unit Staff)

Faculty of Medicine, Health and Human Sciences

Project: Research

Short title	FPI-2265-203
Status	Active
Effective start/end date	8/10/24 → 29/05/29